ClinicalTrials.govpublic full text
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
myelodysplastic syndromes, acute myeloid leukemia, aml, mds, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862869
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.